These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24455772)

  • 21. Implementation and Evaluation of Gradient Strip Antimicrobial Susceptibility Testing in US Public Health Laboratories to Respond to Resistant Gonorrhea.
    Raphael BH; Pham CD; Sharpe S; Mauk K; Harvey A; Khubbar M; Triplett L; Soge OO; Denny M; Palavecino EL; Finney R; Olsen A; Carlson J; St Cyr SB; Schlanger K; Kersh EN;
    Sex Transm Dis; 2021 Dec; 48(12S Suppl 2):S157-S160. PubMed ID: 34433794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates.
    Hauser C; Hirzberger L; Unemo M; Furrer H; Endimiani A
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1605-11. PubMed ID: 25547354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
    Foerster S; Desilvestro V; Hathaway LJ; Althaus CL; Unemo M
    J Antimicrob Chemother; 2017 Jul; 72(7):1961-1968. PubMed ID: 28431096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates determined by the agar dilution, disk diffusion and Etest methods: comparison of results using GC agar and chocolate agar.
    Liao CH; Lai CC; Hsu MS; Chu FY; Wu MY; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2010 May; 35(5):457-60. PubMed ID: 20188518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
    Singh AE; Gratrix J; Read R; Lovgren M; Drews SJ; Romanowski B; Sutherland K; Talbot J; Martin I
    Sex Transm Dis; 2013 Sep; 40(9):744-50. PubMed ID: 23945428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by Etest compared to Calibrated Dichotomous Sensitivity and Clinical Laboratory Standards Institute disc diffusion techniques.
    Mal PB; Jabeen K; Farooqi J; Unemo M; Khan E
    BMC Microbiol; 2016 Oct; 16(1):236. PubMed ID: 27724873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010.
    Carannante A; Prignano G; Cusini M; Matteelli A; Dal Conte I; Ghisetti V; D'Antuono A; Cavrini F; Antonetti R; Stefanelli P
    Clin Microbiol Infect; 2012 Jun; 18(6):558-64. PubMed ID: 21966997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
    Cole MJ; Spiteri G; Chisholm SA; Hoffmann S; Ison CA; Unemo M; Van de Laar M
    Euro Surveill; 2014 Nov; 19(45):20955. PubMed ID: 25411689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014.
    Demczuk W; Martin I; Peterson S; Bharat A; Van Domselaar G; Graham M; Lefebvre B; Allen V; Hoang L; Tyrrell G; Horsman G; Wylie J; Haldane D; Archibald C; Wong T; Unemo M; Mulvey MR
    J Clin Microbiol; 2016 May; 54(5):1304-13. PubMed ID: 26935729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of tigecycline alone and antimicrobial combinations against clinical Neisseria gonorrhoeae isolates.
    Lee H; Kim H; Seo YH; Yong D; Jeong SH; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2017 Feb; 87(2):160-162. PubMed ID: 27890419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy for gonorrhoea: in vitro synergy testing.
    Pereira R; Cole MJ; Ison CA
    J Antimicrob Chemother; 2013 Mar; 68(3):640-3. PubMed ID: 23152483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Neisseria gonorrhoeae minimum inhibitory concentrations obtained using agar dilution versus microbroth dilution methods.
    Jacobson RK; Notaro MJ; Carr GJ
    J Microbiol Methods; 2019 Feb; 157():93-99. PubMed ID: 30629964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of decreased susceptibility to extended-spectrum cephalosporins in Neisseria gonorrhoeae in India.
    Sood S; Mahajan N; Verma R; Kar HK; Sharma VK
    Natl Med J India; 2013; 26(1):26-8. PubMed ID: 24066990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Between 2012 and 2023: Results From an Open Italian Cohort.
    Lucente MF; Raccagni AR; Galli L; Lolatto R; Ranzenigo M; Ripa M; Ponta G; Monardo R; Gona F; Clementi N; Burioni R; Carletti S; Castagna A; Nozza S
    Sex Transm Dis; 2024 Aug; 51(8):540-544. PubMed ID: 38647240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae.
    Furuya R; Nakayama H; Kanayama A; Saika T; Iyoda T; Tatewaki M; Matsuzaki K; Kobayashi I; Tanaka M
    J Infect Chemother; 2006 Aug; 12(4):172-6. PubMed ID: 16944253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends of resistance to antimicrobials recommended currently and in the past for management of gonorrhea in the Apex STD center in India and comparison of antimicrobial resistance profile between 2002-2006 and 2007-2012.
    Bala M; Singh V; Bhargava A; Ramesh V
    Sex Transm Dis; 2015 Apr; 42(4):218-22. PubMed ID: 25763675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neisseria gonorrhoeae strain with reduced susceptibilities to extended-spectrum cephalosporins.
    Nguyen D; Gose S; Castro L; Chung K; Bernstein K; Samuel M; Bauer H; Pandori M
    Emerg Infect Dis; 2014 Jul; 20(7):1211-3. PubMed ID: 24964277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of antimicrobial susceptibilities of pharyngeal, rectal, and urethral Neisseria gonorrhoeae isolates among men who have sex with men.
    Kidd S; Zaidi A; Asbel L; Baldwin T; Gratzer B; Guerry S; Kerani RP; Pathela P; Pettus K; Soge OO; Stirland A; Weinstock HS
    Antimicrob Agents Chemother; 2015 May; 59(5):2588-95. PubMed ID: 25691638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.